A widely prescribed medication may offer new hope for patients battling glioblastoma, an aggressive tumor that accounts for the majority of malignant brain cancers in adults and carries one of the bleakest prognoses in oncology. Patients who took gabapentin — a drug commonly used to treat nerve pain and seizures — lived several months longer than those who didn’t, according to a new study. The findings come from a retrospective analysis by research teams at Mass General Brigham and the University of California, San Francisco. (fb)

Annual COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift unveiled Tuesday by the Trump administration. Top officials for the FDA laid out new requirements for access to yearly COVID shots, saying they’d continue to use a streamlined approach that would continue offering them to adults 65 and older as well as children and younger adults with at least one health problem that puts them at higher risk. (fb)